BACKGROUND: Sinus bradycardia is a well-recognized physiological adaptation in endurance athletes, primarily attributed to sinus node remodeling or increased vagal modulation. Although genetic influen...

This marks the first time that researchers have tied this symptom to the novel adulterant

Researchers have identified bradycardia—an abnormally low heart rate—as a symptom of xylazine-opioid overdose. This breakthrough finding from the Icahn School of Medicine at Mount Sinai may help emergency medicine physicians detect whether patients have been exposed to xylazine, a drug that is increasingly found as an additive to the illicit fentanyl supply, particularly in the Northeast.

What began as loss and mourning became an unexpected medical emergency everyone should be warned about.

The Pacemakers Devices Market is a pivotal segment in cardiac rhythm management, providing life-saving solutions for patients with arrhythmias, bradycardia, and other conduction disorders. As cardiovascular disease prevalence rises globally, demand for advanced pacemakers has surged, creating strategic opportunities for medical device manufacturers, healthcare providers, and enterprise stakeholders. This analysis incorporates secondary and LSI keywords such as implantable cardiac devices, cardiac rhythm management solutions, dual-chamber and single-chamber pacemakers, leadless pacemaker technology, remote monitoring pacemaker systems, cardiology device procurement, and hospital cardiac care programs, offering actionable insights for B2B decision-making and strategic planning.